What makes you believe Jun wasn't aware of Anavex and blarcamesine in the first place ... since has been conferring with the FDA re: it's studies throughout? I have to believe Jun was well aware of the situation and, now with Biogen getting accelerated for a drug that has the potential to cause brains to bleed and, a Medicare & Medicaid, likely to not approve a dangerous drug that can kill ... I suspect Jun may already knew which company and their drug should really have the accelerated approval path, don't you?